|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Depreciation | |||||
| Amortization of debt discount and issuance costs | |||||
| Non-cash interest expense | |||||
| PIK interest incurred but not paid on term loan | |||||
| Loss on debt extinguishment | |||||
| Amortization of right-of-use asset | |||||
| Gain on short-term investments | |||||
| Inventory write-downs | |||||
| Other | |||||
| Loss on disposal of property and equipment | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of property and equipment | |||||
| Proceeds from sale of short-term investments | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock in follow-on offering, net of underwriting discounts and commissions | |||||
| Follow-on Offering | |||||
| At-the-Market Equity Offering | |||||
| Repurchase of common stock from KCK Ltd. | |||||
| Proceeds from issuance of common stock under employee plans | |||||
| Taxes withheld and paid related to net share settlement of equity awards | |||||
| Proceeds from At-the-Market offering, net of sales commission | |||||
| At-the-Market Equity Offering | |||||
| Total proceeds from At-the-Market offering, net of sales commission | |||||
| Payment of deferred offering costs | |||||
| Proceeds from debt, net of discounts and issuance costs | |||||
| Repayment of debt | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash at the Beginning of Period | |||||
| Cash, cash equivalents and restricted cash at the End of Period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosures of non-cash investing and financing information: | |||||
| Operating lease right-of-use asset obtained in exchange for lease obligations | |||||
| Deferred offering costs offset against additional paid-in capital | |||||
| Purchase of property and equipment included in accounts payable | |||||
| Net change in accrued liabilities from early exercise of options | |||||
| Reconciliation of cash, cash equivalents and restricted cash to balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...